a close up of a pen


Emerald Health Therapeutics Inc. completes C$13.8M bought deal financing

Date closed: 2/10/2017

Value: C$13.5 million

On February 10, 2017, Emerald Health Therapeutics Inc. (Emerald Health or the Company) closed its bought deal public offering of 10,235,000 units at a price of $1.35 per unit for aggregate gross proceeds of $13,817,250, which included the exercise in full of the underwriters' over-allotment option. Each unit consists of one common share of the Company and one-half of one common share purchase warrant. The offering was underwritten by Eight Capital (formerly Dundee Capital Partners).

Emerald Health, headquartered in Victoria, British Columbia, is engaged in the business of producing and selling medical marijuana. 

BLG represented Eight Capital with a team led by Andrew Powers that included Philippe TardifLinda TuJoseph DiPonio and Danny Lang.